Effects of Motor Imagery and Action Observation on Upper Limb Motor Chances and Cognitive Chances in Parkinson's Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
Parkinson's disease is degenerative, progressive, and chronic. It is considered potentially disabling, in view of the motor alterations, such as bradykinesia, rigidity, and tremor in the upper limbs, and non-motor alterations, such as cognitive ones involving attention, concentration and memory difficulties. Thus, neurorehabilitation modalities, such as motor imagery and action observation, have been used. The aim of this research is to investigate the effects of motor imagery and action observation on upper limb motor and cognitive changes in Parkinson's disease. This is a randomized controlled trial type study. The population of the study involves people with Parkinson's disease in stages 1-3 on the Hoehn and Yahr scale, aged 20 to 80 years, who must be on stable medication, have no cognitive impairment with risk of dementia, be able to imagine motor activities and have upper limb motor impairment. The study groups will be: a) motor imagery, observation of action and motor execution; b) motor imagery and motor execution; c) observation of action and motor execution; d) motor imagery and motor execution and exoskeleton; e) observation of action and motor execution and exoskeleton. The interventions of all groups will be an intensive approach of 10 continuous sessions, with a two-day break in the middle of the intervention, totaling two weeks, with each session lasting 40 minutes a day. The data collection steps for the study will involve the pre-test, the interventions, the immediate post-test, and the test after a four-week period without intervention. The instruments that will be used for the evaluations will be: a) part of the Unified Parkinson's Disease Rating Scale (UPDRS-III); b) Test D'évaluation Des Membres Supérieurs Des Personnes Âgées (TEMPA); c) 9-Hole Peg Test to assess upper extremity function; d) Parkinson's Disease Cognitive Assessment Scale; e) Canadian Occupational Performance Measure to identify performance and satisfaction in performing activities in the areas of self-care, productivity, and leisure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2022
CompletedFirst Posted
Study publicly available on registry
January 25, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2024
CompletedApril 25, 2025
April 1, 2025
1.8 years
October 18, 2022
April 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Parkinson's Disease-Cognitive Rating Scale
The Parkinson's Disease Cognitive Rating Scale (PD-CRS) arises from the need for a more comprehensive approach to the cognitive assessment of front-subcortical and cortical functions impaired throughout PD. In PD-CRS there are nine functions assessed, seven involving the "frontal-subcortical": sustained attention, working memory, the immediate and delayed evocation of verbal memory (word list), alternating verbal fluency, verbal fluency of actions, and spontaneous clock drawing; and two involving the "posterior cortical": naming twenty figures by visual confrontation, added to copying the clock drawing. The administration time is approximately 20 minutes, and training is available in the public domain. The total score of the PD-CRS is 134 points, with the ideal cutoff score being 81 points, and a score less than or equal to 64 points indicates PD with dementia.
Pre Test: one day before the intervention; Pos Test: one day after the intervention.
Secondary Outcomes (4)
Unified Parkinson's Disease Rating Scale of the Movement Disorders Society
Pre Test: one day before the intervention; Pos Test: one day after the intervention (last session).
Test TEMPA
Pre Test: one day before the intervention; Pos Test: one day after the intervention (last session).
9-Hole Peg Test
Pre Test: one day before the intervention; Pos Test: one day after the intervention.
Canadian Occupational Performance Measure
Pre Test: one day before the intervention; Pos Test: one day after the intervention (last session).
Study Arms (5)
motor imagery, observation of the action, and execution of the action (GE1)
EXPERIMENTALin the sitting position, the participant will watch the recorded video to observe the action, for two minutes. Soon after, they will close their eyes, and receive the description of the action, through recorded audio of the same action, to imagine it, for two minutes. In the sitting or standing position, depending on the action to be performed, the participant must execute the same action imagined previously, for two minutes. Each session will have five different actions that will be repeated twice, totaling 60 minutes of intervention.
motor imagery and execution of the action (GE2)
EXPERIMENTALin the sitting position, the participant will close his eyes and will receive the description of the action, through recorded audio, to imagine it, for two minutes. Then, in the sitting or standing position, depending on the action to be performed, the participant must execute the same action imagined previously, for two minutes. Each session will have five different actions that will be repeated twice, totaling 40 minutes of intervention.
action observation and action execution (GE3)
EXPERIMENTALin the sitting position, the participant will watch the recorded video to perform the action observation, which will last two minutes. Then, in the sitting or standing position, depending on the action to be performed, the participant must execute the same action observed previously, for two minutes. Each session will have five different actions that will be repeated twice, totaling 40 minutes of intervention.
motor imagery, execution of the action, and exoskeleton (GE4)
EXPERIMENTALin the sitting position, the participant will perform the exoskeleton protocol for 40 minutes. Then, the participant will close his eyes and will receive the description of the action, through recorded audio, to imagine it, for two minutes. In the sitting or standing position, depending on the action to be performed, the participant must execute the same action imagined previously, for two minutes. Each session will have five different actions that will be repeated twice, totaling 80 minutes of intervention.
observation of the action, execution of the action, and exoskeleton (GE5)
EXPERIMENTALin the sitting position, the participant will perform the exoskeleton protocol for 40 minutes. Then, the participant will watch the recorded video to observe the action, for two minutes. Then, in the sitting or standing position, depending on the action to be performed, the participant must execute the same action observed previously, for two minutes. Each session will have five different actions that will be repeated twice, totaling 80 minutes of intervention.
Interventions
Motor imagery (MI) is a cognitive process that involves the ability to perform an action mentally, without the need to perform the movement itself. The perspective that the person uses to imagine can be: internal perspective (first person - imagines himself/herself), which relates to the person's view of the content of the images or to his/her kinesthetic sensation - the person imagines the movement being performed, as if feeling the movement of the action; or external perspective (third person - imagines another person), which relates to the visual imagination of scenes outside the person.
Action observation consists of watching another person acting, or doing a motor task, on video or in real-time.
The term Brain-Machine Interface (BMI) refers to systems that capture brain activity signals, translating them into computer commands to control external devices, with the robotic exoskeletons. The electrodes are positioned on the skull cap.
In the sitting or standing position, depending on the action to be performed, the participant must execute the same action imagined or observed previously.
Eligibility Criteria
You may qualify if:
- have a diagnosis of Parkinson's disease and be in stage 1-3, consistent with a mild and moderate disability;
- be aged between 20 years old to 80 years old;
- be on stable use of medication;
- no dementia;
- be minimally capable of imagining motor activities;
- present motor alteration in the dominant upper limb;
- have signed the Informed Consent Form.
You may not qualify if:
- not present additional central nervous system disorders or other conditions that may affect upper and lower extremity function;
- present with other uncontrolled chronic conditions that may interfere with the participant's safety.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UFCSPA
Porto Alegre, Brazil
Related Publications (1)
Estivalet KM, Pettenuzzo TSA, Mazzilli NL, Ferreira LF, Cechetti F. The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson's disease: A protocol study for a randomized clinical trial. PLoS One. 2025 Apr 7;20(4):e0315148. doi: 10.1371/journal.pone.0315148. eCollection 2025.
PMID: 40193313DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Ph.D Fernanda Cechetti
Study Record Dates
First Submitted
October 18, 2022
First Posted
January 25, 2023
Study Start
February 1, 2023
Primary Completion
November 30, 2024
Study Completion
November 30, 2024
Last Updated
April 25, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share